Down’’s syndrome: protection against cancer and the therapeutic potential of DSCR1

Author： Ryeom Sandra   Baek Kwan-Hyuck   Zaslavsky Alexander  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.5, Iss.8, 2009-10, pp. : 1185-1188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer

By Deep Gagan  

Cancer and Metastasis Reviews, Vol. 29, Iss. 3, 2010-09 ,pp. : 447-463

Springer Publishing Company

Access to resources Recommend Favorite

Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target

By                

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 44-54

Spandidos Publications

Access to resources Recommend Favorite

CMTM1_v17 is a novel potential therapeutic target in breast cancer

By                

Oncology Reports, Vol. 32, Iss. 5, 2014-01 ,pp. : 1829-1836

Spandidos Publications

Access to resources Recommend Favorite

Rac1 is correlated with aggressiveness and a potential therapeutic target for gastric cancer

By  

International Journal of Oncology, Vol. 46, Iss. 3, 2015-01 ,pp. : 1343-1353

Spandidos Publications

Access to resources Recommend Favorite

Transcription Factors as Targets for Cancer Therapy: AP-1 a Potential Therapeutic Target

By  

Current Cancer Therapy Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 1-6

Bentham Science Publishers

Access to resources Recommend Favorite